May 2018 Briefing – Dermatology
Here are what the editors at HealthDay consider to be the most important developments in Dermatology for May 2018. This roundup includes the latest...
Convolutional Neural Network Tops Clinicians for Melanoma ID
CNN receiver operating characteristic curve had higher specificity compared with dermatologists'
Facial Morphing Program May Deter Young Adults From Tanning
At one-month follow-up, less frequent tanning reported for facial morphing participants
Oral Propranolol Seems Safe for Infantile Hemangioma
Good safety profile for children with infantile hemangioma with no prespecified underlying disease
ASHP: SVP, Injectable Opioid Shortages Threaten Patient Care
98.4 percent of respondents report moderate, severe shortages of morphine, hydromorphone, fentanyl
Oral Propranolol Seems Safe for Infantile Hemangioma
Good safety profile for children with infantile hemangioma with no prespecified underlying disease
ASHP: SVP, Injectable Opioid Shortages Threaten Patient Care
98.4 percent of respondents report moderate, severe shortages of morphine, hydromorphone, fentanyl
Certolizumab Looks Promising for Moderate-to-Severe Psoriasis
Higher-dose certolizumab (400 mg) better at cutting symptoms than low-dose (200 mg)
Severe Atopic Eczema Tied to Higher CV Disease Risk
Risk of cardiovascular outcomes was greatest for those with the most active atopic eczema
CDC IDs Outbreak Trends Tied to Treated Recreational Water
Outbreaks with confirmed infectious etiology usually caused by Cryptosporidium, Legionella, Pseudomonas
